Option chain shows key data for Alpha Cognition Inc Ordinary Shares's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Alpha Cognition Inc Ordinary Shares.

Alpha Cognition Inc Ordinary Shares (OTC:ACOGF) Stock, Option Chain

Penny Stocks

ACOGF


  By John Vandermosten, CFA

OTC:ACOGF

READ THE FULL ACOGF RESEARCH REPORT

ACOGF: Bioequivalence Complete

Biotech

Small Cap

General

BIIB

SAVA

SPRC

More than 55 million people worldwide have dementia — with about 60% to 70% of those cases resulting from Alzheimer’s disease — and that number is expected to triple by 2050. 

These Biotechs Are Reportedly Reinvigorating Alzheimer&#39;s Disease Research With Novel Drugs That Push Beyond Traditional Approaches

ACOGF: Resolving to Move Ahead

Alpha Cognition Inc Ordinary Shares

News

VEEV

Veeva, Zifo Announce Product Partnership To Help Biopharmas Modernize Quality Control Operations

West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTBA#NASDAQ">WTBA</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.40 by 5 percent. This is a 55.56 percent increase over earnings of $0.27 per share from the same period last year.

Earnings

Earnings Beats

WTBA

West Bancorp Q4 2024 GAAP EPS $0.42 Beats $0.40 Estimate

Raymond James analyst Daniel Magder initiates coverage on Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) with a Strong Buy rating and announces Price Target of $4.5.

Price Target

Initiation

Analyst Ratings

ELVA

Raymond James Initiates Coverage On Electrovaya with Strong Buy Rating, Announces Price Target of $4.5

Rockwell Automation Expands Advanced Technology Team By Opening New Research Lab In Prague, Czech Republic

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Genmab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>) with a Buy and maintains $50 price target.

Reiteration

GMAB

HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $50 Price Target

IDXX

IDEXX Reports Launch Of IDEXX Cancer Dx, A Diagnostic Panel With Early Detection Of Lymphoma In Dogs

Cannabis

Markets

Aurora Cannabis Has Launched Its First German-cultivated Medical Cannabis Product, Under The Brand IndiMed, Manufactured At Aurora's Facility In Leuna, Germany

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Hoth Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) with a Buy and maintains $4 price target.

HOTH

HC Wainwright & Co. Reiterates Buy on Hoth Therapeutics, Maintains $4 Price Target

<h3>Gainers</h3>
<ul>
<li>Harte-Hanks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HHS#NASDAQ">HHS</a>) shares rose 11.6% to $5.85 during Thursday's pre-market session. The company's market cap stands at $42.6 million. </li>
<li>Society Pass (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPA#NASDAQ">SOPA</a>) shares increased by 7.56% to $1.28. The market value of their outstanding shares is at $4.6 million. </li>
<li>System1 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SST#NYSE">SST</a>) shares rose 5.41% to $0.94. The company's market cap stands at $66.3 million. </li>
<li>Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) shares rose 5.14% to $1.43. The company's market cap stands at $12.4 million. </li>
<li>VS Media Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) shares rose 4.76% to $1.32. The market value of their outstanding shares is at $6.0 million. </li>
<li>Sify Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) stock moved upwards by 4.3% to $3.39. The market value of their outstanding shares is at $1.4 billion. The company's, Q3 earnings came out 4 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>DallasNews (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DALN#NASDAQ">DALN</a>) stock decreased by 21.8% to $5.21 during Thursday's pre-market session. The market value of their outstanding shares is at $27.8 million. </li>
<li>Electronic Arts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) stock decreased by 15.0% to $121.0. The market value of their outstanding shares is at $31.9 billion. </li>
<li>AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) stock decreased by 14.23% to $19.29. The market value of their outstanding shares is at $3.8 billion. </li>
<li>Star Fashion Culture (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STFS#NASDAQ">STFS</a>) stock fell 10.99% to $2.35. The market value of their outstanding shares is at $28.5 million. </li>
<li>Snail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAL#NASDAQ">SNAL</a>) stock fell 6.19% to $2.73. The market value of their outstanding shares is at $100.8 million. </li>
<li>MediaCo Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDIA#NASDAQ">MDIA</a>) shares fell 5.67% to $1.0. The company's market cap stands at $46.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ASST

ASTS

DALN

MDIA

SIFY

SNAL

SOPA

STFS

VSME

12 Communication Services Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Quoin Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNRX#NASDAQ">QNRX</a>) stock moved upwards by 35.2% to $0.8 during Thursday's pre-market session. The market value of their outstanding shares is at $6.5 million. </li>
<li>Hepion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares rose 25.92% to $0.17. The company's market cap stands at $1.1 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares moved upwards by 23.52% to $12.81. The market value of their outstanding shares is at $38.9 million. </li>
<li>Vigil Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) stock rose 23.15% to $2.5. The market value of their outstanding shares is at $102.1 million. </li>
<li>TNF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNFA#NASDAQ">TNFA</a>) shares moved upwards by 17.54% to $1.34. The market value of their outstanding shares is at $3.6 million. </li>
<li>Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) shares moved upwards by 15.2% to $2.5. The company's market cap stands at $130.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) stock declined by 8.4% to $0.24 during Thursday's pre-market session. The market value of their outstanding shares is at $3.0 million. </li>
<li>Rigel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIGL#NASDAQ">RIGL</a>) stock declined by 7.62% to $20.15. The market value of their outstanding shares is at $354.9 million. </li>
<li>Eterna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) shares fell 7.42% to $0.59. The company's market cap stands at $30.2 million. </li>
<li>Channel Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares declined by 7.04% to $2.51. The company's market cap stands at $15.1 million. </li>
<li>Zymeworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYME#NASDAQ">ZYME</a>) stock declined by 6.62% to $13.7. The market value of their outstanding shares is at $947.5 million. </li>
<li>Elicio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) stock declined by 6.43% to $6.99. The market value of their outstanding shares is at $75.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AZTR

CHRO

ELTX

ERNA

HEPA

QNRX

RIGL

TNFA

VIGL

XCUR

ZYME

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>LSI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) stock increased by 13.8% to $22.52 during Thursday's pre-market session. The market value of their outstanding shares is at $671.9 million. As per the news, the Q2 earnings report came out today. </li>
<li>Perma-Fix Envirn Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PESI#NASDAQ">PESI</a>) stock moved upwards by 6.17% to $11.34. The market value of their outstanding shares is at $208.3 million. </li>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) stock moved upwards by 5.88% to $1.98. The market value of their outstanding shares is at $10.5 million. </li>
<li>GE Aero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) shares moved upwards by 5.86% to $199.41. The market value of their outstanding shares is at $215.8 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Simpple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) shares increased by 5.35% to $0.94. The market value of their outstanding shares is at $15.2 million. </li>
<li>Nuburu (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BURU#AMEX">BURU</a>) shares increased by 5.1% to $0.4. The company's market cap stands at $8.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) shares decreased by 30.6% to $6.44 during Thursday's pre-market session. The market value of their outstanding shares is at $447.8 million. </li>
<li>Mynaric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) stock fell 9.09% to $0.5. The market value of their outstanding shares is at $12.6 million. </li>
<li>China Yuchai Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYD#NYSE">CYD</a>) stock declined by 6.71% to $11.0. The market value of their outstanding shares is at $412.7 million. </li>
<li>American Airlines Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) shares decreased by 6.22% to $17.5. The market value of their outstanding shares is at $11.4 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Galaxy Payroll Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) shares decreased by 5.31% to $1.07. The market value of their outstanding shares is at $19.2 million. </li>
<li>Smart Powerr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREG#NASDAQ">CREG</a>) shares declined by 4.43% to $0.6. The company's market cap stands at $5.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BURU

CREG

EVTL

GLXG

LYTS

MYNA

PESI

SPPL

ZCAR

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Kopin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) shares moved upwards by 27.9% to $1.88 during Thursday's pre-market session. The market value of their outstanding shares is at $288.1 million. </li>
<li>U-BX Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBXG#NASDAQ">UBXG</a>) shares rose 15.75% to $3.38. The company's market cap stands at $11.4 million. </li>
<li>Coda Octopus Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODA#NASDAQ">CODA</a>) shares moved upwards by 10.22% to $9.38. The company's market cap stands at $105.0 million. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) stock moved upwards by 8.1% to $2.0. The company's market cap stands at $26.4 million. </li>
<li>AuthID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>) stock moved upwards by 6.41% to $6.3. The company's market cap stands at $68.8 million. </li>
<li>Nortech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSYS#NASDAQ">NSYS</a>) shares increased by 5.88% to $10.97. The company's market cap stands at $30.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) stock decreased by 9.2% to $154.9 during Thursday's pre-market session. The company's market cap stands at $4.1 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock declined by 9.14% to $0.94. </li>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) stock declined by 9.04% to $1.51. The company's market cap stands at $55.7 million. </li>
<li>Blackboxstocks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) shares declined by 8.34% to $5.06. The company's market cap stands at $17.9 million. </li>
<li>VerifyMe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRME#NASDAQ">VRME</a>) stock decreased by 7.5% to $2.22. The company's market cap stands at $23.3 million. </li>
<li>Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) shares fell 7.41% to $3.5. The market value of their outstanding shares is at $895.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMOD

AUID

BLBX

BLND

CODA

KOPN

MOBX

NSYS

PLXS

SOBR

UBXG

VRME

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

The company plans to advance VG-3927 into a Phase 2 trial in the third quarter of 2025; Selects 25mg QD oral as a dose that fully engages desired pharmacology.
"We are very excited by these positive Phase 1 data, which further support continued development of VG-3927 as a potential next-generation therapy for AD," said Ivana Magovčević-Liebisch, Ph.D., J.D., President and Chief Executive Officer of Vigil.&nbsp;
 &nbsp;

Vigil Neuroscience Reports Data From Its Completed Phase 1 Clinical Trial Evaluating VG-3927 For Potential Treatment Of Alzheimer's Disease; Says Candidate Demonstrated Favorable Safety And Tolerability Profile

EVAA Protocol, a lending platform operating on the Ton (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TON</a>) blockchain, on Thursday announced the completion of a private token sale, securing $2.5 million in funding. 
The round saw participation from various venture capital firms, angel investors, and key opinion leaders, including Polymorphic Capital, TON Ventures, and Animoca Ventures.
The capital raised will be used to further develop the protocol&#8217;s infrastructure and expand its footprint within the TON decentralized finance (DeFi) ecosystem. 
Aleksandr Sudeikin, co-founder of EVAA Protocol said, "DeFi technology continues to explode within the TON ecosystem. With our unique product, global community, and financials, we are now in a great position to be a base layer for the whole TON DeFi."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43136512/bitcoin-is-no-threat-to-the-us-dollar-goldman-sachs-ceo-says">Bitcoin Is No &#8216;Threat&#8217; To The US Dollar, Goldman Sachs CEO Says</a>
Since its mainnet launch in early 2024, EVAA has reported attracting 80,000 monthly active users and $50 million in total value locked. The next step in its development will be the launch of its own $EVAA token.
EVAA functions as a lending platform where users can engage in borrowing, lending, shorting, leveraged staking, longing, and hedging. 
The protocol has aligned itself with the TON Foundation's objectives for the growth of the blockchain and DeFi and has plans to reach a wide spectrum of users. 
EVAA is integrated into several platforms such as OKX, Gate, Bitget, Tonkeeper and others. 
Future enhancements include the listing of Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) APY, and listing ecosystem tokens as well. 
The protocol also emphasized user accessibility through its integration with the Telegram messenger app for users managing assets and loans.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43133561/bitcoin-could-drop-up-to-20-as-trump-hope-fades-standard-chartered-warns">Bitcoin Could Drop Up To 20% As Trump &#8216;Hope&#8217; Fades, Standard Chartered Warns</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$TON

$USDT

EVAA Protocol Secures $2.5M In Private Token Sale To Expand TON DeFi

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Repligen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) with a Buy and lowers the price target from $240 to $180.

RGEN

HC Wainwright & Co. Maintains Buy on Repligen, Lowers Price Target to $180

LSI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.20 by 30 percent. This is a 23.81 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $147.734 million which beat the analyst consensus estimate of $129.195 million by 14.35 percent. This is a 35.53 percent increase over sales of $109.005 million the same period last year.

LSI Industries Q2 2025 Adj. EPS $0.26 Beats $0.20 Estimate, Sales $147.734M Beat $129.195M Estimate

First BanCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBP#NYSE">FBP</a>) reported quarterly adjusted earnings of $0.46 per share which beat the analyst consensus estimate of $0.41 by 12.2 percent. This is a 6.12 percent decrease over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $241.50 million which beat the analyst consensus estimate of $236.55 million by 2.09 percent. This is a 22.79 percent increase over sales of $196.68 million the same period last year.

First BanCorp Q4 Adj $0.46 Beats $0.41 Estimate, Sales $241.50M Beat $236.55M Estimate

WIIM

American Airlines shares are trading lower following weak Q1 and FY25 guidance.

Old Republic Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORI#NYSE">ORI</a>) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.70 by 28.57 percent. This is a 30.43 percent increase over earnings of $0.69 per share from the same period last year. The company reported quarterly sales of $2.156 billion which beat the analyst consensus estimate of $2.113 billion by 2.01 percent. This is a 11.08 percent increase over sales of $1.941 billion the same period last year.

Old Republic Intl Q4 2024 Adj. EPS $0.90 Beats $0.70 Estimate, Sales $2.156B Beat $2.113B Estimate

Guidance

American Airlines Sees Q1 Adj. EPS $(0.40)-$(0.20) vs $(0.04) Est., FY25 Adj. EPS $1.70-$2.70 vs $2.42 Est.

Press Releases

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

Alpha Cognition's Oral Therapy ZUNVEYL® Receives FDA Approval to Treat Alzheimer's Disease

Alpha Cognition, Inc. On Track to Secure Financing for Continued Growth

Alpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYL® for Mild to Moderate Alzheimer's Disease

Alpha Cognition Announces Completion of $4.545 Million (USD) Convertible Note and Warrants Bridge Financing

Spartan Capital Securities Serves as Selling Group Member in Alpha Cognition Inc.'s $4.454 Million Convertible Note and Warrants Bridge Financing

Alpha Cognition Announces Change of Officer

Alpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYLTM for Mild to Moderate Alzheimer's Disease

Alpha Cognition Announces Appointment of VP Finance and Accounting

Alpha Cognition Announces Proposed Financing and Share Consolidation in connection with Nasdaq Uplisting

Comments

Alpha Cognition Inc Ordinary Shares

Alpha Cognition Inc Ordinary Shares (ACOGF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga